Siponimod post-reimbursement price in 2023

Siponimod (Siponimod) is a drug mainly used to treat multiple sclerosis (Multiple Sclerosis, referred to as MS). Multiple sclerosis is a chronic autoimmune neurological disease that affects the central nervous system, including the brain and spinal cord, causing the immune system to attack the protective myelin sheath of nerve fibers, interfering with nerve signal transmission, thereby causing a range of different neurological problems.

Siponimod is already on the market in China and has been included in medical insurance. Patients can purchase it domestically. Please consult the local hospital pharmacy for specific prices. For overseas prices, please consult Yaode’s medical consultant.

Siponimod belongs to a class of drugs known as antagonistS1P (Sphingosine-1-phosphate ) receptor modulators. S1PThe receptor is a molecule that affects the movement and distribution of immune system cells. By acting on the S1P receptor, siponimod can regulate the activity of the immune system and reduce the extent of the immune system's attack on the nervous system.

Siponimod's main role is to relieve symptoms and slow the progression of the disease in people with multiple sclerosis. Symptoms of multiple sclerosis often come in the form of recurring attacks, and siponimod can reduce the frequency of these attacks. Siponimod reduces the inflammatory response by reducing the activity of the immune system, thereby reducing the degree of damage to the nervous system. This medication may help reduce further damage to nerve fibers and help protect the function of the central nervous system.

Siponimod is usually available as an oral tablet that patients take once daily. However, its use requires physician supervision and prescription as it may cause some side effects and safety risks. Some common side effects include headache, high blood pressure, nausea, vomiting, increased risk of infection, etc. Therefore, before using siponimod, doctors will assess a patient's medical condition to ensure the drug is appropriate for them and provide necessary monitoring and advice.